(EnergyIndustry.Net, September 14, 2020 ) The report "Dual Chamber Prefilled Syringes Market by Material (Glass and Plastic), Indication (Hemophilia, Schizophrenia, Endometriosis, Erectile Dysfunction, and Diabetes), Product (Liquid/Powder, Liquid/Liquid), and Region - Global Forecast to 2025 ", size is projected to grow from USD 131 million in 2020 to USD 182 million by 2025, at a CAGR of 6.8% between 2020 and 2025. The global dual chamber prefilled syringes market is witnessing growth because of the growing demand for drug delivery systems, with the growing pharmaceutical industry in the emerging economies. The increasing number of lyophilized drugs is another reason for the growing demand for dual chamber prefilled syringes, as this type of drug delivery system increases the life of the drug.
Hemophilia Indication segment estimated to lead the Dual Chamber Prefilled Syringes Market in 2019
The increasing number of patients diagnosed with hemophilia in North America and Europe and having better access to healthcare are expected to drive the demand for dual chamber prefilled syringes in this segment. Also, biologics is the only type of drug that is used for the treatment of hemophilia; this drug is lyophilized and is available only as injections.
Glass material is estimated to be leading segment for Dual Chamber Prefilled syringes
The property of glass to be non-reactive to drugs makes it the preferred choice of material for manufacturing the chambers of dual chamber prefilled syringes. Also, the price of glass syringes is relatively low compared to plastics. These factors will drive the glass in the dual chamber prefilled syringes market.
Browse in-depth TOC on "Dual Chamber Prefilled Syringes Market” 133 - Market Data Tables 36 - Figures 145 - Pages
North America is estimated to account for the largest share of the Dual Chamber Prefilled Syringes Market during the forecast period.
North America is projected to have the largest share in the global Dual Chamber syringes, in 2019. North America is driven by the US, with the country being the largest pharmaceutical market in the world. The high per capita income and better accessibility to healthcare in the US are expected to drive the dual chamber prefilled syringes market in North America.
Nipro Corporation (Japan), Gerresheimer AG (Germany), Vetter Pharma (Germany), Credence Medsystems (US), MAEDA INDUSTRY (Japan), and Arte Corporation (Japan) are the key players operating in the Dual Chamber syringes market. Expansions and new product development are the major strategy adopted players to enhance their positions in the Dual Chamber syringes market.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.